Plus   Neg

Neurocrine Biosciences Inc Q4 adjusted earnings Beat Estimates

Neurocrine Biosciences Inc (NBIX) reported earnings for its fourth quarter that increased from last year.

The company's earnings totaled $34.0 million, or $0.35 per share. This compares with $18.0 million, or $0.19 per share, in last year's fourth quarter.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $102.2 million or $1.05 per share for the period.

Analysts had expected the company to earn $0.75 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 85.8% to $244.1 million from $131.4 million last year.

Neurocrine Biosciences Inc earnings at a glance:

-Earnings (Q4): $102.2 Mln. vs. $38.4 Mln. last year.
-EPS (Q4): $1.05 vs. $0.40 last year.
-Analysts Estimate: $0.75
-Revenue (Q4): $244.1 Mln vs. $131.4 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT